Want to create an interactive transcript for this episode?
Podcast: γ¬γ’γΈγ§γθ±δΌθ©± Daily News Article Podcast
Episode: FDA approves first nasal spray to treat dangerous allergic reactions
Description: U.S. health officials approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.
The Food and Drug Administration (FDA) said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis.
Anaphylaxis occurs when the body's immune system develops a sudden, unexpected reaction to a foreign substance, such as food, insect stings or medications. Common symptoms include hives, swelling, itching, vomiting and difficulty breathing.
The device, marketed as Neffy, could upend treatment for the 33 million to 45 million Americans...